Skip to main content
Retinal DiseaseRare diseaseProcedure

What this study is

This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.

What's being tested

  • Arm 1

    Intervention · PROCEDURE

    Procedure/ Surgery: RB (Retrobulbar) Retrobulbar injection of Bone Marrow Derived Stem Cells (BMSC) Procedure/Surgery: ST (Subtenon) Subtenon injection of Bone Marrow Derived Stem Cells (BMSC) Procedure/Surgery: IV (Intravenous) Intravenous injection of Bone Marrow Derived Stem Cells (BMSC)

Study details

Official title
Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II
Sponsor
MD Stem Cells
Conditions
Retinal Disease · Age-Related Macular Degeneration · Retinitis Pigmentosa · Stargardt Disease · Optic Neuropathy · Nonarteritic Ischemic Optic Neuropathy · Optic Atrophy · Optic Nerve Disease · Glaucoma · Leber Hereditary Optic Neuropathy · Blindness · Vision Loss Night · Vision Loss Partial · Vision, Low · Retinopathy · Maculopathy · Macular Degeneration · Retina Atrophy
Enrolling
500 people
Starts
2016-01
Est. completion
2028-07-31
Design
Open-label, single group
Record
View on ClinicalTrials.gov ↗